Microlin Bio to Acquire Nucleic Acid Therapeutic Assets of Marina Biotech | oneFAPvoice

welcome to oneFAPvoice

- a positively charged Familial Adenomatous Polyposis community.
  • join today!

Microlin Bio to Acquire Nucleic Acid Therapeutic Assets of Marina Biotech


Microlin Bio, Inc., a development stage biotechnology company focused on the development of microRNA based therapeutics for cancer, and Marina Biotech, Inc., a leading nucleic acid-based drug discovery and development company focused on rare diseases, announced that the companies have executed a term sheet under which Microlin intends to acquire Marina’s nucleic acid therapeutics assets.

https://media-www.fapvoice.com/wp-content/uploads/2016/08/20.jpg